MNRGX
Price
$46.77
Change
+$0.25 (+0.54%)
Updated
Nov 19 closing price
Net Assets
18.37M
VSTSX
Price
$311.78
Change
+$1.03 (+0.33%)
Updated
Nov 19 closing price
Net Assets
2.05T
Interact to see
Advertisement

MNRGX vs VSTSX

Header iconMNRGX vs VSTSX Comparison
Open Charts MNRGX vs VSTSXBanner chart's image
Manor Growth
Price$46.77
Change+$0.25 (+0.54%)
VolumeN/A
Net Assets18.37M
Vanguard Total Stock Mkt Idx Instl Sel
Price$311.78
Change+$1.03 (+0.33%)
VolumeN/A
Net Assets2.05T
MNRGX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MNRGX vs. VSTSX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNRGX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.05T vs. MNRGX (18.4M). VSTSX pays higher dividends than MNRGX: VSTSX (1.13) vs MNRGX (0.00). MNRGX was incepted earlier than VSTSX: MNRGX (26 years) vs VSTSX (9 years). MNRGX (0.99) is less costly to investors than VSTSX (0.01). MNRGX is a more actively managed with annual turnover of: 12.05 vs. VSTSX (2.00). MNRGX has a lower initial minimum investment than VSTSX: MNRGX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 10.82 vs. MNRGX (4.89). VSTSX return over 5 years is better than : 77.76 vs. MNRGX (43.70).
MNRGXVSTSXMNRGX / VSTSX
Total Expense Ratio0.990.019,900%
Annual Report Gross Expense Ratio0.990.019,900%
Fund Existence26 years9 years-
Gain YTD11.51611.97796%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets18.4M2.05T0%
Annual Yield % from dividends0.001.13-
Returns for 1 year4.8910.8245%
Returns for 3 years42.4363.9666%
Returns for 5 years43.7077.7656%
Returns for 10 years129.14N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACT37.600.28
+0.75%
Enact Holdings
CME272.49-6.79
-2.43%
CME Group
ANTX1.09-0.03
-2.68%
AN2 Therapeutics
ORIC11.47-0.43
-3.61%
Oric Pharmaceuticals
NAKA0.54-0.02
-4.16%
Kindly MD Inc